Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Cortical Hyperostosis in an Infant on Prolonged Prostaglandin Infusion: Case Report and Literature Review

Abstract

The common side effects associated with the use of prostaglandins in newborn infants include apnoea, hyperthermia, diarrhoea, skin flushing and oedema. Periosteal reaction or cortical thickening of the bones, also known as cortical hyperostosis, is associated with a prolonged use of prostaglandins. This is a radiological diagnosis; therefore, its occurrence is most likely underestimated. We describe an infant who developed cortical hyperostosis simulating osteomyelitis with elevated alkaline phosphatase. The radiologic changes were initially attributed to congenital syphilis. This occurred after a prolonged infusion of prostaglandin E1 for a cyanotic congenital heart disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Donahoo JS, Roland JM, Kan J, Gardner TJ, Kidd BS . Prostaglandin E1 as an adjunct to emergency cardiac operation in neonates. J Thorac Cardiovasc Surg 1981;81:227–231.

    CAS  PubMed  Google Scholar 

  2. Babyn P, Peled N, Manson D, Dagan O, Silver MM, Koren G . Radiologic features of gastric outlet obstruction in infants after long-term prostaglandin administration. Pediatr Radiol 1995;25:41–44.

    Article  CAS  Google Scholar 

  3. Jureidini S, Chase NA, Alpert BS, Vanderzalm T, Sheneflet RE . Soft tissue swelling in two neonates during prostaglandin E1 therapy. Pediatr Cardiol 1986;7:157–160.

    Article  CAS  Google Scholar 

  4. Kaufman MB, El-Chaar GM . Bone and tissue changes following prostaglandin therapy in neonates. Ann Pharmacother 1996;30:269–277.

    Article  CAS  Google Scholar 

  5. Jorgensen HR, Svanholm H, Host A . Bone formation induced in an infant by systemic prostaglandin-E2 administration. Acta Orthop Scand 1988;59:464–466.

    Article  CAS  Google Scholar 

  6. Nadroo AM, Shringari S, Garg M, al-Sowailem AM . Prostaglandin induced cortical hyperostosis in neonates with cyanotic heart disease. J Perinat Med 2000;28:447–452.

    Article  CAS  Google Scholar 

  7. Kalloghlian AK, Frayha HH, deMoor MM . Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion. Eur J Pediatr 1996;155:173–174.

    Article  CAS  Google Scholar 

  8. Woo K, Emery J, Peabody J . Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation. Pediatrics 1994;93:417–420.

    CAS  PubMed  Google Scholar 

  9. Host A, Halken S, Andersen Jr PE . Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease. Pediatr Radiol 1988;18:149–153.

    Article  CAS  Google Scholar 

  10. Silverman FN, Kuhn JP . Caffey's Pediatric X-ray Diagnosis: An Intergrated Imaging Approach. St. Louis: CV Mosby; 1993. p. 1855–1867.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Velaphi, S., Cilliers, A., Beckh-Arnold, E. et al. Cortical Hyperostosis in an Infant on Prolonged Prostaglandin Infusion: Case Report and Literature Review. J Perinatol 24, 263–265 (2004). https://doi.org/10.1038/sj.jp.7211050

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211050

This article is cited by

Search

Quick links